Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders are buying shares of Galectin Therapeutics, Bespoke Extracts, and RENN Fund, indicating their confidence in these companies. Notable transactions include purchases by executives and directors, which could be a positive signal for investors.
July 24, 2024 | 11:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bespoke Extracts CEO Michael Feinsod bought 3,000 shares at $0.07 each. The stock has jumped 51% over the past six months, and insider buying could further boost investor confidence.
The CEO's purchase of shares at a low price, combined with the stock's recent performance, suggests strong confidence in the company's future. This could positively impact the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Galectin Therapeutics Director Kary Eldred acquired 400 shares at $2.39 each. Despite a wider-than-expected quarterly loss reported on May 15, insider buying may indicate confidence in the company's future.
Insider buying often signals confidence in the company's future prospects. Despite the recent quarterly loss, the director's purchase may indicate a belief in the company's long-term potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
RENN Fund President and CEO Murray Stahl acquired 1,499 shares at $1.81 each. The stock has risen 7% over the past month, and insider buying may indicate further positive momentum.
The CEO's purchase of shares at a relatively low price, along with the recent positive performance, suggests confidence in the company's future. This could lead to further gains in the stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100